共 92 条
[21]
Yao CM(2022)Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): in-depth sinus surgery analysis Allergy 6 230-234
[22]
Lee JM(2020)Biologic therapies versus surgical management for aspirin-exacerbated respiratory disease: a review of preliminary data, efficacy, and cost World J Otorhinolaryngol Head Neck Surg 394 1638-1650
[23]
Ryan L(2019)Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials Lancet Lond Engl 14 245-246
[24]
Segarra D(2021)Considerations for the use of biologic agents in patients with chronic rhinosinusitis with nasal polyposis Clin Exp Otorhinolaryngol 9 1409-1419
[25]
Tabor M(2019)Benefits and harms of aspirin desensitization for aspirin-exacerbated respiratory disease: a systematic review and meta-analysis Int Forum Allergy Rhinol 58 538-543
[26]
Parasher A(2020)The Amsterdam Classification of Completeness of Endoscopic Sinus Surgery (ACCESS): a new CT-based scoring system grading the extent of surgery Rhinology undefined undefined-undefined
[27]
Lund VJ(undefined)undefined undefined undefined undefined-undefined
[28]
Kennedy DW(undefined)undefined undefined undefined undefined-undefined
[29]
Hopkins C(undefined)undefined undefined undefined undefined-undefined
[30]
Browne JP(undefined)undefined undefined undefined undefined-undefined